New Survey by Applied Data Research Analyzes Clinical Impact

(Nashua, NH) – Imaging agents that can work at the cellular level are positioned to propel noninvasive diagnostics into a new era. These molecular imaging agents can associate with highly specific markers on the surface of cells to provide unparalleled specificity, creating new opportunities for visualization, targeted drug delivery, and mapping physiological changes over time.

A new imaging technology may hold the key to not only stopping heart attacks in their tracks but also preventing them for ever occurring. For the first time, researchers at Mount Sinai School of Medicine have shown the use multi-detector computed tomography (CT) imaging along with a novel contrast agent know as N1177 can detect dangerous, high-risk plaque which cause heart attack and stroke.